Due to the nature of ultra-short-acting opioid remifentanil of high time-varying,complex compartment model and low-accuracy of plasma concentration prediction,the traditional estimation method of population pharmacoki...Due to the nature of ultra-short-acting opioid remifentanil of high time-varying,complex compartment model and low-accuracy of plasma concentration prediction,the traditional estimation method of population pharmacokinetics parameters,nonlinear mixed effects model(NONMEM),has the abuses of tedious work and plenty of man-made jamming factors.The Elman feedback neural network was built.The relationships between the patients’plasma concentration of remifentanil and time,patient’age,gender,lean body mass,height,body surface area,sampling time,total dose,and injection rate through network training were obtained to predict the plasma concentration of remifentanil,and after that,it was compared with the results of NONMEM algorithm.In conclusion,the average error of Elman network is 6.34%,while that of NONMEM is 18.99%.The absolute average error of Elman network is 27.07%,while that of NONMEM is 38.09%.The experimental results indicate that Elman neural network could predict the plasma concentration of remifentanil rapidly and stably,with high accuracy and low error.For the characteristics of simple principle and fast computing speed,this method is suitable to data analysis of short-acting anesthesia drug population pharmacokinetic and pharmacodynamics.展开更多
Gastrointestinal stromal tumors(GISTs),the most prevalent mesenchymal tumors,often have poor outcomes due to high recurrence rates.However,the specific risk factors for GISTs,particularly those concerning the innate i...Gastrointestinal stromal tumors(GISTs),the most prevalent mesenchymal tumors,often have poor outcomes due to high recurrence rates.However,the specific risk factors for GISTs,particularly those concerning the innate immune-inflammatory response,remain poorly understood.This editorial highlights key prognostic factors that impact GIST progression and prognosis,while discussing the findings of a recent study that investigated the prognostic value of systemic inflammatory markers:systemic immune-inflammation index,neutrophil/lym-phocyte ratio,platelet/lymphocyte ratio,and monocyte/lymphocyte ratio,on recurrence-free survival in GIST patients.This editorial examines strategies to enhance the clinical applicability of the nomogram developed in the study,ensuring its effectiveness for robust implementation.Future directions outlined in the editorial stress the importance of integrating molecular insights,including KIT and PDGFRA mutations,tumor staging,and mitotic rates to refine predictive models.The editorial also underscores the value of multi-center studies to enhance the generalizability and clinical relevance of these approaches.By bridging inflammatory biomarkers with genetic and clinicopathologic factors,a more comprehensive understanding of GIST pathophysiology can be developed,paving the way for improved management strategies and patient outcomes.This perspective serves as a call to action for continued research into the interplay between genetic mutations,inflammatory marker modulation,and GIST progression,aiming to expand the scope of personalized oncology through a deeper understanding of GIST progression.展开更多
基金Project(31200748)supported by the National Natural Science Foundation of China
文摘Due to the nature of ultra-short-acting opioid remifentanil of high time-varying,complex compartment model and low-accuracy of plasma concentration prediction,the traditional estimation method of population pharmacokinetics parameters,nonlinear mixed effects model(NONMEM),has the abuses of tedious work and plenty of man-made jamming factors.The Elman feedback neural network was built.The relationships between the patients’plasma concentration of remifentanil and time,patient’age,gender,lean body mass,height,body surface area,sampling time,total dose,and injection rate through network training were obtained to predict the plasma concentration of remifentanil,and after that,it was compared with the results of NONMEM algorithm.In conclusion,the average error of Elman network is 6.34%,while that of NONMEM is 18.99%.The absolute average error of Elman network is 27.07%,while that of NONMEM is 38.09%.The experimental results indicate that Elman neural network could predict the plasma concentration of remifentanil rapidly and stably,with high accuracy and low error.For the characteristics of simple principle and fast computing speed,this method is suitable to data analysis of short-acting anesthesia drug population pharmacokinetic and pharmacodynamics.
文摘Gastrointestinal stromal tumors(GISTs),the most prevalent mesenchymal tumors,often have poor outcomes due to high recurrence rates.However,the specific risk factors for GISTs,particularly those concerning the innate immune-inflammatory response,remain poorly understood.This editorial highlights key prognostic factors that impact GIST progression and prognosis,while discussing the findings of a recent study that investigated the prognostic value of systemic inflammatory markers:systemic immune-inflammation index,neutrophil/lym-phocyte ratio,platelet/lymphocyte ratio,and monocyte/lymphocyte ratio,on recurrence-free survival in GIST patients.This editorial examines strategies to enhance the clinical applicability of the nomogram developed in the study,ensuring its effectiveness for robust implementation.Future directions outlined in the editorial stress the importance of integrating molecular insights,including KIT and PDGFRA mutations,tumor staging,and mitotic rates to refine predictive models.The editorial also underscores the value of multi-center studies to enhance the generalizability and clinical relevance of these approaches.By bridging inflammatory biomarkers with genetic and clinicopathologic factors,a more comprehensive understanding of GIST pathophysiology can be developed,paving the way for improved management strategies and patient outcomes.This perspective serves as a call to action for continued research into the interplay between genetic mutations,inflammatory marker modulation,and GIST progression,aiming to expand the scope of personalized oncology through a deeper understanding of GIST progression.
